A sensor technology that combines ultrasound-driven particle transport with evanescent wave scattering on leaky waveguide surfaces to detect low concentrations of microbes in minutes, without the need for reagents. Designed for in-line, rapid microbial monitoring.
This solution addresses the need for rapid, reagent-free detection of low numbers of microbes in liquid samples. It combines ultrasound waves, which actively transport microbial cells to a sensor surface, with leaky waveguide (LW) sensors that detect captured cells through evanescent wave scattering. By co-locating a low sound pressure region with the waveguide surface, microbes are concentrated on the sensor where their higher refractive index relative to the surrounding medium produces a detectable optical signal. The approach aims to deliver sensitive microbial detection in minutes, supporting applications such as water quality monitoring, food safety testing, clinical diagnostics, and bioprocess control where timely results are critical.
The technology is at an early-to-mid stage of development. Prior proof-of-concept work has demonstrated the core principle of ultrasound-integrated leaky waveguide detection, achieving detection of 10^3 cells/ml within 3 minutes. However, that earlier implementation used waveguide materials and metal films that produced high optical losses, lacked recognition elements for microbial capture, and employed non-optimal instrumentation and flow cell design. Current and planned work focuses on addressing each of these limitations through hydrogel waveguide development, surface functionalisation with recognition elements, microfluidic flow cell optimisation, and redesigned signal collection and transducer placement. The platform is not yet commercially available and requires further validation to confirm improved sensitivity and readiness for deployment in real-world settings.
The University of Birmingham is a comprehensive public research university of significant scale in the UK’s second city. For industry, a campus‑adjacent research park provides office and wet‑lab space, including the BioHub biomedical incubator managed by University of Birmingham Enterprise. Clinical collaboration is enabled through Birmingham Health Partners, aligning the university with NHS hospital trusts for translational studies and access to patient pathways. Energy and sustainability ventures tap the Birmingham Energy Innovation Centre and wider facilities at Tyseley Energy Park, creating a proving ground for low‑carbon technologies and scale‑up. Research is backed by competitive UK funding, including UKRI councils, Innovate UK, and NIHR, and a dedicated tech transfer office manages IP, licensing, and spinouts to speed corporate partnerships.